Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE
- PMLiVE

Pharmaceutical Market Europe – April 2024

Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change

- PMLiVE

Pharmaceutical Market Europe – March 2024

Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges

PME Feb 2024

Pharmaceutical Market Europe – February 2024

Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics

- PMLiVE

Pharmaceutical Market Europe – January 2024

Interview with AstraZeneca’s Ed Piper on patient outcomes; Pharma trends and predictions for 2024; Precision medicine in chronic diseases

- PMLiVE

Pharmaceutical Market Europe – December 2023

Full coverage of the 23rd annual PMEAs; Virtual patient care – a glimpses of an exciting future; Rare diseases – the importance of screening for SMA

- PMLiVE

Pharmaceutical Market Europe – November 2023

A focus on real-world evidence and its capabilities; transforming clinical trials with connected drug devices; the impact of AI and ChatGPT on pharma

- PMLiVE

Pharmaceutical Market Europe – October 2023

Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments

- PMLiVE

Pharmaceutical Market Europe – September 2023

Accelerating clinical trial diversity; the fight against AMR; innovation in chronic diseases; the importance of actinic keratosis awareness

- PMLiVE

Pharmaceutical Market Europe – July/August 2023

Communiqué Awards 2023: celebrating 25 years! See page 26 for full coverage of the event; Creating truly effective communications excellence

- PMLiVE

Pharmaceutical Market Europe – June 2023

Powering creativity to work in harmony with science and data; Driving conscious inclusion in companies; AI – the next paradigm shift in healthcare

- PMLiVE

Pharmaceutical Market Europe – May 2023

Achieving better patient pathways with a focus on the patient; Why TB remains a major global public health challenge; The impact of rare diseases

- PMLiVE

Pharmaceutical Market Europe – April 2023

New beginnings – learning the language of change; Future-proofing clinical development; Supply chain challenges faced by the pharma industry